These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19293613

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B, Pauli C, Botter SM, Bode-Lesniewska B, Fuchs B.
    BMC Cancer; 2015 May 09; 15():379. PubMed ID: 25956431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L, Deng S, Zhang F, Liang Y, Huang Z.
    World J Surg Oncol; 2018 Feb 23; 16(1):39. PubMed ID: 29471883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
    Urakawa H, Nishida Y, Naruse T, Nakashima H, Ishiguro N.
    Clin Orthop Relat Res; 2009 Nov 23; 467(11):2932-8. PubMed ID: 19326179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2887-95. PubMed ID: 17653803
    [Abstract] [Full Text] [Related]

  • 15. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
    Xu M, Xu S, Yu X.
    World J Surg Oncol; 2014 Nov 11; 12():341. PubMed ID: 25391880
    [Abstract] [Full Text] [Related]

  • 16. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
    Zhang B, Pang QJ, Zhang HJ, Yuan Y.
    Zhongguo Gu Shang; 2011 Dec 11; 24(12):982-6. PubMed ID: 22276503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
    Hattinger CM, Michelacci F, Sella F, Magagnoli G, Benini S, Gambarotti M, Palmerini E, Picci P, Serra M, Ferrari S.
    Histopathology; 2015 Sep 11; 67(3):338-47. PubMed ID: 25600168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.